Supporting the recognition of October 2025 as "National Breast Cancer Awareness Month".
H. Res. 806 is a House of Representatives resolution that formally supports recognizing October 2025 as National Breast Cancer Awareness Month. Introduced in the 119th Congress, the measure is a symbolic expression of the House’s support for increasing public awareness about breast cancer, promoting research, early detection, and treatment, and addressing the challenges faced by those affected. It cites statistics on incidence, mortality, survival by cancer stage, and disparities among racial and ethnic groups, and it notes the ongoing burden of metastatic breast cancer and the needs of survivors and their families. As a resolution, it does not create new laws or authorize funding; instead, it signals legislative support and can influence public discussion and policy priorities.
Key Points
- 1The resolution designates October 2025 as National Breast Cancer Awareness Month and expresses the House’s support for awareness, research, and efforts to find a cure.
- 2It provides national statistics: estimated 319,000+ new breast cancer cases in 2025 and about 42,000 deaths, highlighting the range of outcomes by cancer stage (highly favorable for localized, much lower for metastatic disease).
- 3It highlights disparities: higher mortality for Black women, breast cancer being a leading cancer in Hispanic women, and relatively stagnant mortality among American Indian/Alaska Native women since 1990.
- 4It notes that there are more than 168,000 individuals living with metastatic breast cancer and emphasizes the lack of a current cure, with ongoing treatment focused on quality of life.
- 5It points out issues unique to younger women and the need for access to timely, affordable health care, including screening, diagnosis, and treatment, and it frames these topics as priorities for policymakers.
- 6The resolution, once adopted, indicates support and urges policymakers to address the issues facing the breast cancer community, though it does not prescribe specific policy changes or funding.